An interesting and potential mechanism of action of GLP-1 receptor agonists on prostate cancer seems to result from a direct effect on obesity and metabolic status of the patient with prostate cancer
GLP-1 Receptor Agonists and Vision Issues: Clinical Considerations GLP-1 receptor agonists (GLP-1 RAs) such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro) have transformed the treatment of type 2 diabetes and obesity
Recent Findings Clinical trials have proven that the widely used GLP-1 analogues have pleotropic effects beyond those on weight and glucose metabolism and appear to confer favourable cardiovascular and renal outcomes
In May, the reality TV star revealed that she lost 16lbs (7kg) in three weeks so that she would be able to slip into a dress that belonged to Marilyn Monroe
PNPO mutations are treated with high doses of P5P (active form), thus providing the active form of B6 without the need for conversion
Scientific studies continue to highlight its importance, making it a popular choice for those seeking to improve their well-being through evidence-backed supplementation
